Business
SweetBiotix® Sampling
OptiBiotix Health plc is inviting shareholders and prospective investors to an event in London in June 2026 to demonstrate its SweetBiotix products, following a breakthrough in manufacturing that resulted in higher yields of a purer, more concentrated, and better-tasting product with reduced costs. The event will provide an overview of the commercial progress of the company's first and second-generation products and their market entry strategies. Interested parties are encouraged to sign up via a provided link to receive further details on location and timings. Disclaimer*
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\n \nSweetBiotix® Sampling\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes announces plans to demonstrate its SweetBiotix products to shareholders.\n \nThe Company reported a breakthrough in the manufacture of its SweetBiotix products on 24 November 2025 leading to higher yields of purer, more concentrated, better tasting product with lower ingredient and production costs.\n \nThe Company is now in a position to demonstrate this product to shareholders at an event in London to be held in June 2026, subject to the availability of a suitable venue. In order to assess attendance and venue size, the Company would encourage all existing shareholders and prospective investors who are interested in attending to sign up (it should take less than one minute) using the link below:-\n \n1. Visit https://optibiotix.com/s/3eda67\n2. Follow the prompts on the top right hand side of the website marked SIGN UP\n3. Complete your account profile (name/email address)\n \nOnce registered, OptiBiotix can update investors on location and timings and send invitations to interested shareholders. The meeting will give an overview of the commercial progress of the Company's first generation products , second generation products and their route to market, and sampling of SweetBiotix.\n \n \n\n\n\n\nFor further information, please contact: OptiBiotix Health plc\n\n\nwww.optibiotix.com\n\n\n\n\nNeil Davidson, Chairman\n\n\n \n\n\n\n\nStephen O'Hara, Chief Executive\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\nAbout OptiBiotix : www.optibiotix.com\nOptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), OptiBiotix Health has developed a range of technologies and commercialised products which modulate the human microbiome to help prevent and manage human disease. Since the Group's inception it has created a wide range of microbiome-based ingredients and products including prebiotic products like SlimBiome®, WellBiome®, SweetBiotix® and Microbiome Modulators within its core OptiBiotix Health plc (OPTI) busine...